Schering/Merck Zetia On Track For $1 Bil. In 2004; Lipid Market Growing Rapidly
This article was originally published in The Pink Sheet Daily
Executive Summary
The Schering-Plough/Merck cholesterol drug joint venture is likely to top $1 bil. in revenues during 2004